Pacific Edge appoints new chief commercial officer

Cancer diagnostics company, Pacific Edge, has announced the appointment of James Vaughn as its new chief commercial officer.

Vaughn, who has over 30 years of experience in the pharmaceutical, medical device, and clinical diagnostics sectors, will be responsible for driving the adoption of Pacific Edge's Cxbladder product.

The company said the CCO role was created to lead its global commercial execution, following the inclusion of Cxbladder Triage in the American Urological Association guideline for the evaluation of microhematuria.

Vaughn previously served as the chief commercial officer of ClearNote Health and held multiple roles at Genomic Health.

His appointment comes after the departure of David Levison, who served as the president of Pacific Edge Diagnostics USA for 10 years.